Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations

[1]  W. Lipkin,et al.  Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome , 2016, Molecular Psychiatry.

[2]  L. Jason,et al.  Myalgic Encephalomyelitis: Symptoms and Biomarkers , 2015, Current neuropharmacology.

[3]  Mady Hornig,et al.  Distinct plasma immune signatures in ME/CFS are present early in the course of illness , 2015, Science Advances.

[4]  K. Mizuno,et al.  Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study , 2014, The Journal of Nuclear Medicine.

[5]  I. Stojanovic,et al.  IL‐17 and Glutamate Excitotoxicity in the Pathogenesis of Multiple Sclerosis , 2014, Scandinavian journal of immunology.

[6]  W. Baumgärtner,et al.  Effector molecules released by Th1 but not Th17 cells drive an M1 response in microglia , 2014, Brain, Behavior, and Immunity.

[7]  J. Warren,et al.  Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults , 2012, Cancer.

[8]  Richard D. Smith,et al.  Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome , 2011, PloS one.

[9]  M. Edström,et al.  Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid , 2010, Multiple sclerosis.

[10]  Daniel J Clauw,et al.  A chronic fatigue syndrome – related proteome in human cerebrospinal fluid , 2005, BMC neurology.

[11]  T. Martins.  Development of Internal Controls for the Luminex Instrument as Part of a Multiplex Seven-Analyte Viral Respiratory Antibody Profile , 2002, Clinical and Vaccine Immunology.

[12]  D. Vignali.  Multiplexed particle-based flow cytometric assays. , 2000, Journal of immunological methods.

[13]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[14]  D. Cox,et al.  An Analysis of Transformations , 1964 .

[15]  Tarek A-Z K Gaber,et al.  Multiple Sclerosis/Chronic Fatigue Syndrome overlap: When two common disorders collide. , 2014, NeuroRehabilitation.

[16]  BMC Bioinformatics BioMed Central Methodology article , 2007 .

[17]  P. Flor-Henry,et al.  Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .

[18]  L. Breiman.  Random Forests , 2001, Machine Learning.

[19]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .

[20]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[21]  L. Calabrese,et al.  Chronic fatigue syndrome and a disorder resembling Sjögren's syndrome: preliminary report. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  D. Peterson,et al.  Chronic fatigue syndrome in northern Nevada. , 1991, Reviews of infectious diseases.

[23]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .